Impact of UV Modifying Factors on the Incidence of Keratinocyte Carcinomas in Solid Organ Transplant Recipients: a Systematic Review
Keywords:
keratinocyte, organ transplant recipient, ultraviolet radiation, Fitzpatrick Skin Type, Sun exposureAbstract
Introduction: Solid organ transplant recipients (SOTR) are at an increased risk for developing keratinocyte carcinomas (KC). Four ultraviolet (UV) modifying factors have been identified that impact the incidence of KC: Fitzpatrick Skin Type (FST), race, sun exposure, and sun-protective factors.
Objectives: We conducted a systematic review to summarize the association between UV modifying factors and the incidence of KC in SOTR.
Methods: We systematically searched PubMed, Scopus, and Web of Science databases, and after screening for inclusion and exclusion criteria, we included 13 studies with 6,910 solid organ transplant recipients in our analysis.
Results: Our review found that lower FST (I-II), white and Latinx populations, lack of regulated sunscreen application, and occupational and residential sun exposure are individual risk factors among solid organ transplant recipients for KC incidence. Although previous studies showed an increased SCC:BCC ratio, some studies found a contradictory increased BCC:SCC ratio. Limitations include few research studies that analyze these UV modifying factors and a lack of incorporating both varying immunosuppressant factors and transplantation follow-up times.
Conclusions: These findings support the need for dermatological advice in increased risk patient demographic populations, lower FST and white and Latinx populations, and subsequently moderating sun exposure and protective factors.
References
Sánchez G, Nova J, Rodriguez-Hernandez AE, et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database Syst Rev. 2016;7(7):CD011161. DOI:10.1002/14651858.CD011161.pub2. PMID: 27455163. PMCID: PMC6457780.
Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001;344(13):975-983. DOI:10.1056/NEJM200103293441306 PMID: 11274625.
Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet. 2010;375(9715):673-685. DOI:10.1016/S0140-6736(09)61196-X. PMID: 20171403.
Zamoiski RD, Yanik E, Gibson TM, et al. Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers. Cancer Res. 2017;77(15):4196-4203. DOI:10.1158/0008-5472.CAN-16-3291. PMID: 28615224. PMCID: PMC5540772.
Greenberg JN, Zwald FO. Management of Skin Cancer in Solid-organ Transplant Recipients: A Multidisciplinary Approach. Dermatol Clin. 2011;29(2):231-241, ix. DOI:10.1016/j.det.2011.02.004. PMID: 21421148.
Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370(9581):59-67. DOI:10.1016/S0140-6736(07)61050-2. PMID: 17617273.
Crow LD, Jambusaria‐Pahlajani A, Chung CL, et al. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transpl Int. 2019;32(12):1268-1276. DOI:10.1111/tri.13520. PMID: 31502728.
Sachdeva S. Fitzpatrick skin typing: applications in dermatology. Indian J Dermatol Venereol Leprol. 2009;75(1):93-96. DOI:10.4103/0378-6323.45238. PMID: 19172048.
Brenner M, Hearing VJ. The Protective Role of Melanin Against UV Damage in Human Skin†. Photochem Photobiol. 2008;84(3):539-549. DOI: 10.1111/j.1751-1097.2007.00226.x. PMID: 18435612. PMCID: PMC2671032.
Watson M, Holman DM, Maguire-Eisen M. Ultraviolet Radiation Exposure and Its Impact on Skin Cancer Risk. Semin Oncol Nurs. 2016;32(3):241-254. DOI: 10.1016/j.soncn.2016.05.005. PMID: 27539279. PMCID: PMC5036351.
Wu S, Han J, Vleugels RA, et al. Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer. 2014;110(7):1855-1861. DOI:10.1038/bjc.2014.43. PMID: 24595003. PMCID: PMC3974077.
Xiang F, Lucas R, Hales S, Neale R. Incidence of nonmelanoma skin cancer in relation to ambient UV radiation in white populations, 1978-2012: empirical relationships. JAMA Dermatol. 2014;150(10):1063-1071. DOI:10.1001/jamadermatol.2014.762. PMID: 25103031.
English DR, Armstrong BK, Kricker A, Winter MG, Heenan PJ, Randell PL. Case-control study of sun exposure and squamous cell carcinoma of the skin. Int J Cancer. 1998;77(3):347-353. DOI:10.1002/(sici)1097-0215(19980729)77:3<347::aid-ijc7>3.0.co;2-o. PMID: 9663594.
Iannacone MR, Wang W, Stockwell HG, et al. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. BMC Cancer. 2012;12:417. DOI:10.1186/1471-2407-12-417. PMID: 22994655. PMCID: PMC3517361.
Zanetti R, Rosso S, Martinez C, et al. The multicentre south European study “Helios”. I: Skin characteristics and sunburns in basal cell and squamous cell carcinomas of the skin. Br J Cancer. 1996;73(11):1440-1446. DOI:10.1038/bjc.1996.274. PMID: 8645595. PMCID: PMC2074488.
Gabros S, Nessel T, Zito P. Sunscreens And Photoprotection. StatPearls. Published online November 15, 2021. Available from https://www.ncbi.nlm.nih.gov/books/NBK537164/Accessed April 2, 2022.
van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged Prevention of Squamous Cell Carcinoma of the Skin by Regular Sunscreen Use. Cancer Epidemiol Biomarkers Prev. 2006;15(12):2546-2548. DOI:10.1158/1055-9965.EPI-06-0352. PMID: 17132769.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. DOI:10.1136/bmj.n71. PMID: 33782057. PMCID: PMC8005924.
Gogia R, Binstock M, Hirose R, Boscardin WJ, Chren MM, Arron ST. Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol. 2013;68(4):585-591. DOI:10.1016/j.jaad.2012.09.030. PMID: 23107311. PMCID: PMC3562416.
Moloney FJ, Almarzouqi E, O’Kelly P, Conlon P, Murphy GM. Sunscreen use before and after transplantation and assessment of risk factors associated with skin cancer development in renal transplant recipients. Arch Dermatol. 2005;141(8):978-982. DOI:10.1001/archderm.141.8.978. PMID: 16103326.
De Rosa N, Paddon VL, Liu Z, Glanville AR, Parsi K. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients. JAMA Dermatol. 2019;155(6):716. DOI:10.1001/jamadermatol.2018.4789. PMID: 30865218. PMCID: PMC6563540.
Ng JC, Cumming S, Leung V, Chong AH. Accrual of non-melanoma skin cancer in renal-transplant recipients: Experience of a Victorian tertiary referral institution: NMSC accrual in OTR. Australas J Dermatol. 2014;55(1):43-48. DOI: 10.1111/ajd.12072. PMID: 23808627.
Caforio ALP, Fortina AB, Piaserico S, et al. Skin Cancer in Heart Transplant Recipients: Risk Factor Analysis and Relevance of Immunosuppressive Therapy. Circulation. 2000;102(suppl_3). DOI:10.1161/circ.102.suppl_3.III-222. PMID: 11082391.
Ramsay HM, Fryer AA, Hawley CM, Smith AG, Harden PN. Non-melanoma skin cancer risk in the Queensland renal transplant population. Br J Dermatol. 2002;147(5):950-956. DOI:10.1046/j.1365-2133.2002.04976.x. PMID: 12410706.
Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis. 2003;41(3):676-683. DOI:10.1053/ajkd.2003.50130. PMID: 12612993.
García J, Suárez-Varela M, Vilata J, Marquina A, Pallardó L, Crespo J. Risk Factors for Non-melanoma Skin Cancer in Kidney Transplant Patients in a Spanish Population in the Mediterranean Region. Acta Derm Venerol. 2013;93(4):422-427. DOI:10.2340/00015555-1525. PMID: 23303600.
Savoia P, Stroppiana E, Cavaliere G, et al. Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study. Eur J Dermatol. 2011;21(2):242-247. DOI: 10.1684/ejd.2011.1272. PMID: 21382788.
Dusendang JR, Carlson E, Lee DS, et al. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication. J Am Acad Dermatol. 2022;86(3):598-606. DOI: 10.1016/j.jaad.2021.07.065. PMID: 34384835.
Kang W, Sampaio MS, Huang E, Bunnapradist S. Association of Pretransplant Skin Cancer With Posttransplant Malignancy, Graft Failure and Death in Kidney Transplant Recipients. Transplantation. 2017;101(6):1303-1309. DOI:10.1097/TP.0000000000001286. PMID: 27336396.
Ulrich C, Jürgensen JS, Degen A, et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol. 2009;161 Suppl 3:78-84. DOI:10.1111/j.1365-2133.2009.09453.x. PMID: 19775361.
Green A, Williams G, Neale R, et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet. 1999;354(9180):723-729. DOI:10.1016/S0140-6736(98)12168-2. PMID: 10475183.
Zavattaro E, Fava P, Veronese F, et al. Identification of Risk Factors for Multiple Non-Melanoma Skin Cancers in Italian Kidney Transplant Recipients. Medicina (Kaunas). 2019;55(6):E279. DOI:10.3390/medicina55060279. PMID: 31208110. PMCID: PMC6631054.
Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation. 1996;61(5):715-721. DOI:10.1097/00007890-199603150-00008. PMID: 8607173.
Tessari G, Girolomoni G. Nonmelanoma skin cancer in solid organ transplant recipients: update on epidemiology, risk factors, and management. Dermatol Surg. 2012;38(10):1622-1630. DOI:10.1111/j.1524-4725.2012.02520.x. PMID: 22805312.
Iannacone MR, Sinnya S, Pandeya N, et al. Prevalence of Skin Cancer and Related Skin Tumors in High-Risk Kidney and Liver Transplant Recipients in Queensland, Australia. J Invest Dermatol. 2016;136(7):1382-1386. DOI: 10.1016/j.jid.2016.02.804. PMID: 26968258.
Vadnerkar A, Nguyen MH, Mitsani D, et al. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant. 2010;29(11):1240-1244. DOI: 10.1016/j.healun.2010.05.022. PMID: 20591690.
Rodríguez-Acosta ED, Calva-Mercado JJ, Alberú-Gómez J, Vilatoba-Chapa M, Domínguez-Cherit J. [Patients with solid organ transplantation and skin cancer: determination of risk factors with emphasis in photoexposure and immunosuppressive regimen. Experience in a third level hospital]. Gac Med Mex. 2015;151(1):19-24.
Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation. 1972;14(4):407-417. DOI:10.1097/00007890-197210000-00001. PMID: 4345337. PMCID: PMC3006181.
Jensen P, Hansen S, Møller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol. 1999;40(2):177-186. DOI:10.1016/S0190-9622(99)70185-4. PMID: 10025742.
Gjersvik P, Hansen S, Møller B, et al. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients? Transpl Int. 2000;13(7):S380-S381. DOI:10.1007/s001470050366. PMID: 11112037.
Otley C, Pittelkow M. Skin cancer in liver transplant recipients. Liver Transpl. 2000;6(3):253-262. DOI:10.1016/S1527-6465(05)80001-2. PMID: 10827224.
Ulrich C, Kanitakis J, Stockfleth E, Euvrard S. Skin Cancer in Organ Transplant Recipients-Where Do We Stand Today? Am J Transplant. 2008;8(11):2192-2198. DOI: 10.1111/j.1600-6143.2008.02386.x. PMID: 18782290.
Published
Issue
Section
License
Copyright (c) 2023 Syed Rahman, Fahad Ahmed, Amir Amanullah, Adel Haque
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
